Give 15% off, earn 10% back on every order they place.
Research compounds — ≥98% supplier batch spec, selected lots independently tested

Retatrutide 10mg + Bacteriostatic Water 5ml + 2 x 3ml syringes + 5 x 1ml insulin syringes. Everything you need to begin research. For research purposes only. Bundle price: save EUR 27.47 vs buying the peptide, bacteriostatic water and syringe packs separately (about EUR 106.46 on their own).

Tirzepatide 10mg + Bacteriostatic Water 5ml + 2 x 3ml syringes + 5 x 1ml insulin syringes. Everything you need to begin research. For research purposes only. Bundle price: save EUR 25.97 vs buying the peptide, bacteriostatic water and syringe packs separately (about EUR 79.96 on their own).

Research-grade Liraglutide. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
10mgResearch-grade Retatrutide + Cagrilintide Blend. ≥ 98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.

Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies. Triple hormone receptor agonism (GIP/GLP-1/Glucagon) Metabolic pathway modulation research Energy homeostasis and body composition studies For research purposes only.

Tirzepatide is a 39-amino acid dual GIP/GLP-1 receptor agonist peptide studied for metabolic and insulinotropic signalling pathways in vitro research. Features a C-20 fatty diacid moiety enabling extended pharmacokinetic profile. Shipped to a ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Key research areas: Dual incretin receptor signaling and glucose-dependent insulin secretion Insulin-sensitivity and metabolic-homeostasis pathways studied in research models Body-weight and energy-balance signalling studied in research models For research purposes only. Not for human consumption.

Semaglutide is a long-acting GLP-1 receptor agonist peptide analogue (CAS 910463-68-2), supplied by CertaPeptides as lyophilized powder (injectable format) and oral tablets (3mg, 7mg) for laboratory research use only (≥98% supplier batch specification; selected lots independently tested, 99.3% avg across published reports). It is widely used as a long-acting reference GLP-1R agonist in incretin receptor-pharmacology and preclinical metabolic-model research. For laboratory research use only. Not for human consumption.

Research-grade Mazdutide. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.